IMR OpenIR
Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
Alternative TitleDiagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
Huang DongHui; Sun Hao; Shi JingPu
2016
Source PublicationChinese Medical Journal
ISSN0366-6999
Volume129Issue:5Pages:570-577
AbstractBackground: Many studies have explored the diagnostic performance of soluble suppression of tumorigenicity-2 (sST2) for heart failure (HF), but the results are inconsistent. Here, we performed a meta-analysis to assess the role of sST2 in the diagnosis of HF. Methods: We searched PubMed, Web of Science, Cochrane Library, China National Knowledge Infrastructure, and Wanfang Database from inception to April 2015. Studies that investigated the diagnostic role of sST2 for HF were reviewed. The numbers of true-positive, false-positive, false-negative, and true-negative results were extracted to calculate pooled diagnostic odds ratio (DOR) with 95% confidence interval (CI) and the summary receiver operating characteristic curve and area under the curve (AUC). The Spearman correlation coefficient was used to check the threshold effect. The Cochran Q statistic (P 50%) were used to assess the nonthreshold effect. Meta-regression was conducted to explore the source of heterogeneity; subgroup analysis showed the results in different subgroups. Finally, the Deeks' test was performed to assess the publication bias. Results: Nine articles including 10 studies were included in the meta-analysis. The pooled sensitivity was 0.84 (95% CI: 0.81–0.86), and pooled specificity was 0.74 (95% CI: 0.72–0.76). The summary DOR was 8.49 (95% CI: 4.54–15.86), and AUC was 0.81 (standard error: 0.03). The Spearman correlation coefficient identified the nonsignificant threshold effect (coefficient = 0.49, P = 0.148), but the nonthreshold effect heterogeneity was significant (Cochran Q = 58.52, P < 0.0001; I2 = 84.6%). Meta-regression found that characteristics of controls might be the suggestive source of nonthreshold effect heterogeneity (P = 0.095). Subgroup analysis found that DOR was 5.65 and 7.86, respectively for the controls of hospital patients and healthy populations. Deeks' test demonstrated that there was no publication bias (P = 0.616). Conclusion: The meta-analysis illustrated that sST2 might play a role in diagnosing HF.
Other AbstractBackground: Many studies have explored the diagnostic performance of soluble suppression of tumorigenicity-2 (sST2) for heart failure (HF), but the results are inconsistent. Here, we performed a meta-analysis to assess the role of sST2 in the diagnosis of HF. Methods: We searched PubMed, Web of Science, Cochrane Library, China National Knowledge Infrastructure, and Wanfang Database from inception to April 2015. Studies that investigated the diagnostic role of sST2 for HF were reviewed. The numbers of true-positive, false-positive, false-negative, and true-negative results were extracted to calculate pooled diagnostic odds ratio ( DOR ) with 95% confidence interval ( CI ) and the summary receiver operating characteristic curve and area under the curve (AUC). The Spearman correlation coefficient was used to check the threshold effect. The Cochran Q statistic ( P < 0.05) and the inconsistency index ( I 2 > 50%) were used to assess the nonthreshold effect. Meta-regression was conducted to explore the source of heterogeneity; subgroup analysis showed the results in different subgroups. Finally, the Deeks’ test was performed to assess the publication bias. Results: Nine articles including 10 studies were included in the meta-analysis. The pooled sensitivity was 0.84 (95% CI : 0.81–0.86), and pooled specificity was 0.74 (95% CI : 0.72–0.76). The summary DOR was 8.49 (95% CI : 4.54–15.86), and AUC was 0.81 (standard error: 0.03). The Spearman correlation coefficient identified the nonsignificant threshold effect (coefficient = 0.49, P = 0.148), but the nonthreshold effect heterogeneity was significant (Cochran Q = 58.52, P < 0.0001; I 2 = 84.6%). Meta-regression found that characteristics of controls might be the suggestive source of nonthreshold effect heterogeneity ( P = 0.095). Subgroup analysis found that DOR was 5.65 and 7.86, respectively for the controls of hospital patients and healthy populations. Deeks’ test demonstrated that there was no publication bias ( P = 0.616). Conclusion: The meta-analysis illustrated that sST2 might play a role in diagnosing HF.
KeywordBiomarker Medicine R Diagnosis Heart Failure Meta-analysis Soluble Suppression of Tumorigenicity-2
Indexed ByCSCD
Language英语
CSCD IDCSCD:5650418
Citation statistics
Document Type期刊论文
Identifierhttp://ir.imr.ac.cn/handle/321006/150708
Collection中国科学院金属研究所
Affiliation中国科学院金属研究所
Recommended Citation
GB/T 7714
Huang DongHui,Sun Hao,Shi JingPu. Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure[J]. Chinese Medical Journal,2016,129(5):570-577.
APA Huang DongHui,Sun Hao,&Shi JingPu.(2016).Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.Chinese Medical Journal,129(5),570-577.
MLA Huang DongHui,et al."Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure".Chinese Medical Journal 129.5(2016):570-577.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Huang DongHui]'s Articles
[Sun Hao]'s Articles
[Shi JingPu]'s Articles
Baidu academic
Similar articles in Baidu academic
[Huang DongHui]'s Articles
[Sun Hao]'s Articles
[Shi JingPu]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Huang DongHui]'s Articles
[Sun Hao]'s Articles
[Shi JingPu]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.